Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable inje… Read more
Ypsomed Holding AG (YPHDF) - Total Assets
Latest total assets as of September 2025: $1.21 Billion USD
Based on the latest financial reports, Ypsomed Holding AG (YPHDF) holds total assets worth $1.21 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ypsomed Holding AG - Total Assets Trend (2002–2025)
This chart illustrates how Ypsomed Holding AG’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ypsomed Holding AG - Asset Composition Analysis
Current Asset Composition (March 2025)
Ypsomed Holding AG's total assets of $1.21 Billion consist of 32.1% current assets and 67.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.7% |
| Accounts Receivable | $203.48 Million | 15.3% |
| Inventory | $85.75 Million | 6.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $310.42 Million | 23.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2002–2025)
This chart illustrates how Ypsomed Holding AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ypsomed Holding AG's current assets represent 32.1% of total assets in 2025, a decrease from 38.2% in 2002.
- Cash Position: Cash and equivalents constituted 2.7% of total assets in 2025, up from 1.7% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is intangible assets at 23.3% of total assets.
Ypsomed Holding AG Competitors by Total Assets
Key competitors of Ypsomed Holding AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Ypsomed Holding AG - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Ypsomed Holding AG generates 0.56x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Ypsomed Holding AG generates $6.58 in net profit.
Ypsomed Holding AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.47 | 0.66 | 0.62 |
| Quick Ratio | 1.19 | 0.51 | 0.40 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $118.31 Million | $ -172.25 Million | $ -118.05 Million |
Ypsomed Holding AG - Advanced Valuation Insights
This section examines the relationship between Ypsomed Holding AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.00 |
| Latest Market Cap to Assets Ratio | 1.05 |
| Asset Growth Rate (YoY) | 20.8% |
| Total Assets | $1.33 Billion |
| Market Capitalization | $1.40 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Ypsomed Holding AG's assets above their book value (1.05 x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Ypsomed Holding AG's assets grew by 20.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Ypsomed Holding AG (2002–2025)
The table below shows the annual total assets of Ypsomed Holding AG from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $1.33 Billion | +20.79% |
| 2024-03-31 | $1.10 Billion | +27.79% |
| 2023-03-31 | $861.88 Million | +13.87% |
| 2022-03-31 | $756.91 Million | +5.47% |
| 2021-03-31 | $717.68 Million | +5.82% |
| 2020-03-31 | $678.24 Million | +15.40% |
| 2019-03-31 | $587.75 Million | +17.49% |
| 2018-03-31 | $500.24 Million | +18.60% |
| 2017-03-31 | $421.80 Million | +8.47% |
| 2016-03-31 | $388.87 Million | +7.66% |
| 2015-03-31 | $361.21 Million | +1.89% |
| 2014-03-31 | $354.53 Million | +3.73% |
| 2013-03-31 | $341.79 Million | +4.44% |
| 2012-03-31 | $327.27 Million | -51.49% |
| 2011-03-31 | $674.63 Million | +1.91% |
| 2010-03-31 | $662.01 Million | +4.71% |
| 2009-03-31 | $632.22 Million | -0.94% |
| 2008-03-31 | $638.23 Million | +2.48% |
| 2007-03-31 | $622.79 Million | -6.45% |
| 2006-03-31 | $665.70 Million | +1.10% |
| 2005-03-31 | $658.48 Million | +31.49% |
| 2004-03-31 | $500.78 Million | +250.29% |
| 2003-03-31 | $142.96 Million | +22.07% |
| 2002-03-31 | $117.12 Million | -- |